7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-09-30 2013-06-30 2013-03-31 2012-09-30 2012-06-30 2012-03-31 2011-09-30 2011-06-30 2011-03-31 2010-09-30 2010-06-30 2010-03-31 2009-09-30 2009-06-30 2009-03-31 2008-09-30 2008-06-30 2008-03-31 2007-09-30 2007-06-30 2007-03-31 2006-09-30 
      
    		                                                                     
      operating activities
    		                                                                     
      net income including the noncontrolling interests in subsidiaries
    		106,095,000 96,691,000 103,876,000 83,854,000 90,341,000 19,225,000 75,010,000 86,047,000 74,266,000 73,002,000 71,466,000 61,635,000 67,574,000 50,758,000 54,597,000 70,997,000 73,486,000 53,479,000 74,346,000 101,272,000 86,684,000 84,801,000 63,265,000 85,089,000 73,585,000 63,840,000 54,611,000 61,632,000 61,994,000 38,667,000 60,006,000 131,974,000 57,241,000 54,659,000 51,027,000 57,229,000 58,908,000 56,603,000 48,774,000 49,169,000 44,136,000 42,263,000 36,418,000 39,604,000 37,259,000 37,314,000 35,645,000                       
      adjustments to reconcile net income to net cash provided (used) by operating activities
    		                                                                     
      depreciation and amortization
    		5,633,000 5,637,000 5,416,000 5,556,000 5,714,000 5,534,000 5,625,000  6,093,000 6,702,000 8,022,000  6,774,000 6,961,000 7,462,000                                                       
      share-based compensation expense
    		5,669,000 6,392,000 11,117,000 6,043,000 6,170,000 6,302,000 10,269,000 6,782,000 7,488,000 8,997,000 10,680,000 7,179,000 8,899,000 9,432,000 9,288,000 7,011,000 6,307,000 7,760,000 9,216,000 6,445,000 6,289,000 6,468,000 7,467,000 5,909,000 5,960,000 6,078,000 7,110,000 5,649,000 5,476,000 5,801,000 6,967,000 5,218,000 5,056,000 5,562,000 6,672,000 5,233,000 4,285,000 5,691,000 7,236,000 5,330,000 5,003,000 5,451,000 6,901,000 5,091,000 4,773,000 5,530,000 6,317,000 4,864,000 5,044,000 5,714,000 4,577,000 4,799,000 5,583,000 4,387,000 4,619,000 5,458,000 4,081,000 4,997,000 5,625,000 4,212,000 4,295,000 5,730,000 4,462,000 3,612,000 3,653,000 2,987,000 3,240,000 3,021,000  
      (gain) loss on disposal of assets
    		-2,845,000 -1,702,000 -1,530,000 -327,000 -1,468,000 521,000 -278,000 417,000 244,000 -882,000 481,000 858,000 4,723,000 -587,000 -150,000 11,000 -1,812,000 -3,479,000 -1,684,000 -208,000 418,000 1,072,000 100,000  -680,000 199,000 492,000                            -156,000 -2,454,000              
      benefit for deferred income taxes
    		20,797,000 -1,380,000 531,000 -3,779,000 -6,525,000 -7,281,000 2,650,000 8,236,000 -2,608,000 -1,300,000 -76,000 -11,749,000 -4,806,000 -4,505,000 2,342,000 -462,000 817,000 15,081,000 3,597,000 6,262,000 5,270,000 3,891,000 2,746,000 1,496,000 618,000 642,000 4,696,000                              3,124,000 9,933,000 946,000 -2,736,000 2,146,000 -9,203,000 916,000   -1,023,000 -1,398,000 428,000  
      consolidation/(deconsolidation) of other entities
    		-7,845,000 0 0  443,000 -3,168,000 409,000  5,666,000 0 -2,176,000  0 0 -20,000  -650,000 -760,000 11,789,000                                                   
      net unrealized (gain) loss on investments
    		-4,787,000 -9,511,000 568,000 3,537,000 -6,468,000 336,000 -1,334,000 -11,503,000 3,198,000 856,000 -5,974,000 -11,042,000 2,110,000 21,468,000 11,847,000 -1,992,000 2,469,000 -2,764,000 322,000 -14,006,000 -6,267,000 -14,878,000 15,748,000   -764,000 -2,162,000                                           
      net sales (purchases) of investments—consolidated investment companies
    		-61,085,000 -68,303,000 -15,141,000 -6,300,000 -13,307,000 -10,221,000 1,257,000 1,983,000 -18,468,000 -9,460,000 -8,383,000 6,046,000 17,003,000 -12,282,000 -30,937,000 -49,772,000 -65,248,000 -13,272,000 -51,127,000 -5,462,000 -11,791,000 783,000 3,492,000                                               
      impairment of intangible asset
    		0   0 0                                                                 
      other changes in assets and liabilities:
    		                                                                     
      increase in receivables
    		-2,965,000 5,448,000 -10,955,000 8,733,000 1,223,000 4,414,000 2,978,000 3,413,000 9,655,000 -25,404,000 -15,232,000 -8,904,000 4,527,000 -9,833,000 9,843,000 2,748,000 -3,019,000 191,000 6,742,000 5,656,000   8,687,000  -5,503,000 6,504,000 -575,000                                -2,357,000       -838,000 -803,000 -1,060,000  
      increase in prepaid expenses and other assets
    		-35,664,000 -5,028,000 1,280,000 5,693,000 7,881,000 -1,624,000 7,921,000 1,359,000 2,407,000 15,658,000 1,324,000 42,316,000 -20,208,000 -634,000 -2,892,000 6,388,000 6,391,000 838,000 -3,342,000 -24,271,000      -4,809,000 2,693,000                                 5,025,000   3,871,000       
      increase in accounts payable and accrued expenses
    		38,050,000 22,157,000 -101,218,000 37,399,000 34,806,000 30,885,000 -93,731,000 38,569,000 22,326,000 15,353,000 -61,621,000 27,653,000 30,024,000 35,198,000 -88,206,000 30,404,000 30,954,000 33,893,000 -101,616,000 28,106,000      29,339,000 -72,337,000                                          14,562,000 
      increase in other liabilities
    		42,006,000 -31,614,000 20,355,000 -8,017,000 -1,661,000 -22,580,000 3,255,000 -9,846,000 -4,632,000 -12,378,000 6,909,000 -19,987,000 -4,601,000 2,787,000 6,872,000 -5,132,000 -13,887,000 -16,046,000 11,789,000 16,106,000 -38,526,000 21,264,000 10,108,000   -8,796,000 6,281,000 1,080,000 5,516,000 -9,094,000 11,070,000 731,000 2,664,000 -20,797,000 22,187,000    12,780,000 2,617,000 2,307,000 -6,755,000 9,628,000 2,884,000 2,816,000 -9,191,000 9,741,000 -735,000 -2,230,000 3,957,000   4,735,000 -51,000 738,000 9,069,000 311,000   2,898,000 1,851,000 -242,000 -247,000 1,966,000 2,554,000 2,695,000 761,000 2,401,000  
      net cash provided (used) by operating activities
    		103,059,000 18,787,000 14,299,000 126,700,000 117,149,000 88,674,000 14,031,000 129,632,000 105,635,000 71,144,000 5,420,000 132,413,000 112,019,000 98,763,000 -19,247,000 69,427,000 46,005,000 84,964,000 -30,013,000 129,783,000 90,061,000 124,146,000 29,251,000 122,599,000 99,918,000 95,665,000 16,758,000                                           
      investing activities
    		                                                                     
      purchases of investments—affiliates and other
    		-2,870,000 -980,000 -1,758,000 -2,458,000 -16,447,000 -2,893,000 -25,718,000 -44,399,000 -2,355,000 -9,662,000 -1,583,000 -4,038,000 -13,525,000 -3,073,000 -2,008,000 -2,208,000 -1,578,000 -3,832,000 -1,811,000 -6,463,000      -13,796,000 -1,566,000                                           
      cash paid for business acquisitions, net of cash acquired
    		0           -28,111,000    5,324,000 -5,324,000 0 0 0 0   0 0                                             
      proceeds from redemptions of investments—affiliates and other
    		9,750,000 4,505,000 1,230,000 44,362,000 9,207,000 12,448,000 53,874,000 7,337,000 5,754,000 18,053,000 4,160,000 1,381,000 13,322,000 6,746,000 1,321,000 2,699,000 19,376,000 11,449,000 2,466,000 5,078,000 2,510,000 1,713,000 2,192,000 48,429,000 30,728,000 726,000 1,185,000 297,000 17,567,000 847,000 1,572,000                                       
      cash paid for property and equipment
    		-1,430,000 -786,000 -972,000 -505,000 3,028,000 -5,978,000 -569,000 -2,112,000 -2,081,000 -2,983,000 -739,000 -278,000 -1,205,000 -1,036,000 -1,853,000 -2,668,000 -4,498,000 -1,096,000 -2,159,000 -4,941,000      -3,804,000 -5,060,000                           -1,433,000 -3,530,000 -1,857,000 -1,560,000 -2,437,000 -1,129,000 -2,296,000          
      other investing activities
    		0 -6,000,000 -28,000 0                                                                  
      net cash provided (used) by investing activities
    		5,450,000 -16,016,000 -1,528,000 41,399,000 -8,312,000 3,577,000 27,587,000 -39,174,000 1,318,000 5,408,000 1,838,000 -31,046,000 -1,408,000 2,637,000 -2,540,000 -2,177,000 7,976,000 6,521,000 -1,504,000 -6,326,000      -16,089,000 -5,441,000     109,996,000 -162,000 2,821,000 5,314,000                -18,452,000 19,999,000 9,659,000            8,800,000     
      financing activities
    		                                                                     
      dividends paid
    		-26,365,000 -26,846,000 -25,305,000 -25,223,000 -25,573,000 -110,281,000 -23,734,000 -24,130,000 -24,703,000 -25,111,000 -24,149,000 -24,111,000 -24,145,000 -24,706,000 -24,953,000 -26,096,000 -26,329,000 -26,551,000 -26,788,000 -126,153,000      -27,332,000 -27,217,000                           -25,019,000 -25,092,000 -24,950,000 -24,727,000 -24,770,000 -154,454,000 -24,679,000 -24,680,000 -24,553,000 -305,396,000 -24,450,000 -21,371,000 -21,481,000 -21,610,000 -18,675,000 -18,938,000 
      purchases of treasury stock
    		-21,000 -65,524,000 -120,131,000 -23,446,000 -28,901,000 -46,242,000 -39,026,000 -65,053,000 -64,098,000 -41,353,000 -6,562,000 -6,925,000 -6,612,000 -91,266,000 -113,338,000 -135,923,000 -14,453,000 -38,900,000 -39,073,000 -13,614,000      -709,000 -1,485,000                           -8,764,000 -7,426,000 -3,677,000 -3,169,000 -5,562,000 -558,000 -12,464,000 -5,499,000 -843,000 -844,000 -37,245,000 -2,042,000 -61,155,000 -10,506,000 -42,983,000 -32,180,000 
      distributions to noncontrolling interests in subsidiaries
    		-11,410,000 -13,536,000 -8,367,000 -12,851,000 -10,567,000 -4,430,000 -3,410,000 -7,393,000 -14,889,000 -14,454,000 -3,224,000 -3,835,000 -16,620,000 -1,185,000 -4,339,000                                       18,000 -9,000 -1,530,000              
      contributions from noncontrolling interests in subsidiaries
    		67,660,000 74,205,000 16,235,000 36,614,000 13,503,000 16,303,000 2,724,000 5,040,000 35,323,000 19,684,000 12,776,000 5,023,000 4,494,000 15,314,000 30,340,000                                       0 568,000 5,943,000              
      other financing activities
    		0 8,000 0 1,340,000 1,000 0 38,000 1,259,000 15,000 0 0 -5,728,000 6,913,000 15,000 -9,499,000 1,416,000 30,000 30,000 -2,008,000 -218,000      171,000 0             0 0 0 0                    44,000 -22,000 -22,000 -21,000 -21,000 -94,000 -78,000 
      net cash provided (used) by financing activities
    		29,864,000 -31,693,000 -137,568,000 -26,273,000 -51,549,000 -145,049,000 -63,526,000 -91,485,000 -68,352,000 -61,234,000 -22,016,000 -78,523,000 -43,023,000 -101,828,000 54,861,000 -36,089,000 -101,573,000 -62,820,000 -48,990,000 -153,322,000   50,400,000   -31,590,000 -35,919,000                              -40,959,000             
      effect of exchange rates on cash, cash equivalents, restricted cash and restricted cash equivalents
    		-3,072,000 12,356,000 5,266,000  10,416,000 75,000 -1,412,000  -4,531,000 3,604,000 2,047,000  -12,263,000 -13,212,000 -4,505,000  -4,584,000 556,000 1,270,000       -2,510,000 2,264,000                                           
      net increase in cash, cash equivalents, restricted cash and restricted cash equivalents
    		135,301,000 -16,566,000 -119,531,000 128,952,000 67,704,000 -52,723,000 -23,320,000 5,718,000 34,070,000 18,922,000 -12,711,000 32,650,000 55,325,000 -13,640,000 28,569,000 31,608,000 -52,176,000 29,221,000 -79,237,000 -20,615,000 45,251,000 -30,520,000 65,008,000 50,999,000 17,948,000 45,476,000 -22,338,000   49,539,000 9,407,000                                       
      cash, cash equivalents, restricted cash and restricted cash equivalents, beginning of period
    		0 0 507,567,000 0 0 0 386,954,000 0 0 0 340,955,000 -1,000 0 0 238,052,000 0 0 0 308,635,000 0 0 0 249,511,000 0 0 0 157,426,000 0 0 0 316,809,000                                       
      cash, cash equivalents, restricted cash and restricted cash equivalents, end of period
    		135,301,000 -16,566,000 388,036,000 128,952,000 67,704,000 -52,723,000 363,634,000 5,718,000 34,070,000 18,922,000 328,244,000 32,649,000 55,325,000 -13,640,000 266,621,000 31,608,000 -52,176,000 29,221,000 229,398,000 -20,615,000 45,251,000 -30,520,000 314,519,000 50,999,000 17,948,000 45,476,000 135,088,000 39,903,000 -258,232,000 49,539,000 326,216,000                                       
      less: restricted cash recorded in other current assets
    		0 0 0 -529,000 187,000 -369,000 3,374,000 -388,000 -128,000 147,000 3,867,000 257,000 -462,000 -311,000 4,289,000 -30,000 -149,000 -1,909,000 6,507,000 364,000 242,000 -14,000 5,863,000                                               
      less: restricted cash and restricted cash equivalents recorded in other long-term assets
    		9,000 14,000 469,000 -8,000 -2,000 -5,000 478,000 -114,000 -5,000 1,000 394,000 130,000 -1,000 -18,000 289,000 3,000 13,000 3,000 286,000 49,000 2,000 3,000 307,000 9,000 -275,000 0 603,000 14,000 -3,000 -24,000 607,000                                       
      cash and cash equivalents
    		135,292,000 -16,580,000 387,567,000 129,489,000 67,519,000 -52,349,000 359,782,000 6,220,000 34,203,000 18,774,000 323,983,000 32,262,000 55,788,000 -13,311,000 262,043,000 31,635,000 -52,040,000 31,127,000 222,605,000 -21,028,000 45,007,000 -30,509,000 308,349,000 52,661,000 16,552,000 45,476,000 134,485,000 39,889,000 -258,229,000 49,563,000 325,609,000                                       
      cash paid for business acquisitions
    		  0 -2,707,000 -12,000 -399,000 -118,000 -1,208,000 0 0 -857,000                   0 0          0 0 0           -2,700,000 -543,000 -44,732,000 -8,195,000 -32,775,000 -5,157,000 -3,152,000 -20,165,000 -762,000   0   -8,383,000  
      adjustments to reconcile net income to net cash from operating activities
    		                                                                     
      subsidiary share-based compensation expense
    		       0 0 0 0 0 0 0 707,000 1,855,000 2,557,000 2,517,000 2,482,000 2,382,000 2,164,000 2,087,000 2,153,000 1,864,000 2,125,000                                             
      consolidation/(deconsolidation) of investment companies
    		                   0                                                  
      proceeds from new borrowings
    		       0 0 0 0 0 0 0 488,300,000 213,500,000 82,150,000 0 0 0 0 0 100,000,000 0 0 0 8,800,000 8,500,000 61,150,000                                         
      payments on debt
    		       0 0 0 0 -50,000,000 0 0 -311,650,000 -92,300,000 -45,000,000 -5,000,000 -5,000,000 -15,000,000      -5,000,000 -13,800,000                                           
      effect of exchange rates on cash, cash equivalents, restricted cash, and restricted cash equivalents
    		                                                                     
      supplemental disclosure of cash flow information
    		                                                                     
      cash paid during the year for:
    		                                                                     
      income taxes
    		                                                                     
      interest
    		                                                                     
      depreciation and other amortization
    		                 7,329,000 7,236,000 7,222,000 7,253,000 7,181,000 6,907,000 6,757,000 6,714,000 5,230,000 7,221,000 6,320,000 5,424,000 2,705,000 2,638,000 2,849,000 2,609,000 2,595,000 2,584,000 2,480,000 2,239,000 2,508,000 2,351,000 2,351,000 2,333,000 2,344,000 2,507,000 2,693,000 2,581,000 2,686,000 2,744,000 2,701,000 2,503,000 2,492,000 2,570,000 2,543,000 2,767,000 3,212,000 3,486,000 4,603,000 5,126,000 5,478,000 5,470,000 5,730,000 5,667,000 6,550,000 5,954,000 6,062,000 6,100,000 6,600,000 5,622,000 6,907,000 6,878,000 
      cash paid for asset acquisitions
    		                                                                     
      payments to acquire additional equity in fhl
    		           0                                                          
      notes to the consolidated financial statements
    		                                                                     
      payments to acquire additional equity in hfml
    		               -2,190,000                                                      
      distributions to noncontrolling interest in subsidiaries
    		                -1,178,000 -1,016,000 -1,898,000       -541,000 -2,260,000                              -2,705,000 -4,484,000 -2,481,000 -2,442,000 -2,589,000 -2,122,000        
      contributions from noncontrolling interest in subsidiaries
    		                66,903,000 8,632,000 25,762,000  3,212,000 6,225,000 5,577,000  687,000 1,821,000 43,000  3,262,000 663,000 500,000  596,000 681,000 2,818,000  3,266,000 5,343,000 5,431,000  5,670,000 4,754,000 5,785,000  7,875,000 1,168,000 2,049,000 11,397,000 4,815,000 5,024,000 631,000 12,752,000 347,000    2,061,000 2,010,000 3,396,000 4,348,000 164,000 2,174,000        
      amortization of deferred sales commissions
    		                 197,000 237,000 279,000 320,000 362,000 408,000 452,000 495,000 538,000 592,000 648,000 705,000 775,000 839,000 1,445,000 1,701,000 2,271,000 2,608,000 3,001,000 3,123,000 2,952,000 2,904,000 3,280,000 3,716,000 4,040,000 4,018,000 3,784,000 3,339,000 2,937,000 2,639,000 2,330,000 2,274,000 2,113,000 1,961,000 1,790,000 1,625,000 1,337,000 1,880,000 2,782,000 2,988,000 3,114,000 3,172,000 5,104,000 4,959,000 4,873,000 7,761,000 8,801,000 9,361,000 11,299,000 12,074,000 12,258,000 12,600,000 
      proceeds from shareholders for share-based compensation
    		                  15,000     1,238,000   0 1,222,000 15,000 106,000 101,000 1,209,000 0   1,214,000 73,000 149,000 0 1,453,000 17,000 1,000 81,000 1,469,000 97,000 0 480,000 45,000   0 9,000 0 0 1,236,000 13,917,000 196,000 0 487,000 459,000 3,317,000 921,000 16,394,000       
      consolidation/deconsolidation of investment companies
    		                               0                                      
      payments on contingent consideration liabilities
    		                                                                     
      loss on derivative
    		                                                                     
      net sales of investments—consolidated investment companies
    		                         -6,235,000 8,136,000 7,394,000 1,559,000 7,243,000 500,000                                       
      net unrealized gain on investments
    		                           2,521,000 -748,000 644,000 1,905,000                                       
      adoption of new accounting pronouncement
    		                               0 0 0 0                                   
      deferred sales commissions paid
    		                                                     -2,283,000 -2,228,000 -2,254,000 -2,633,000 -2,666,000 -2,796,000 -3,269,000 -3,097,000 -2,378,000 -2,282,000 -3,503,000 -3,611,000 -1,608,000 -1,745,000 -5,229,000 -5,667,000 
      contingent deferred sales charges received
    		                           0 0   301,000 327,000 545,000 612,000 559,000 543,000 515,000 578,000 524,000 694,000 583,000 549,000 486,000 419,000 302,000 585,000 625,000 358,000 425,000 297,000 400,000 352,000 330,000 355,000 506,000 484,000 592,000 685,000 709,000 863,000 1,164,000 1,718,000 1,883,000 2,407,000 2,883,000 3,094,000 3,323,000 3,778,000 
      distributions from equity investments
    		                                                                     
      net cash from operating activities
    		                           119,912,000 -50,016,000 88,290,000 48,096,000 79,654,000 91,795,000 65,904,000 33,024,000 77,253,000 86,366,000 63,507,000 25,645,000 80,961,000 79,643,000 57,917,000 14,663,000 80,792,000 46,452,000 47,488,000 17,750,000 54,728,000 47,706,000 19,773,000 156,603,000 53,034,000 30,256,000 70,810,000 27,662,000 46,500,000 71,259,000 66,313,000 33,419,000 88,076,000 56,942,000 55,714,000 78,920,000 60,167,000 75,611,000 93,062,000 63,207,000 71,856,000 74,565,000 
      capex
    		                           0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -5,740,000 -2,162,000 -2,104,000 -2,230,000 -1,357,000 -816,000 -1,350,000 -907,000 
      free cash flows
    		                           119,912,000 -50,016,000 88,290,000 48,096,000 79,654,000 91,795,000 65,904,000 33,024,000 77,253,000 86,366,000 63,507,000 25,645,000 80,961,000 79,643,000 57,917,000 14,663,000 80,792,000 46,452,000 47,488,000 17,750,000 54,728,000 47,706,000 19,773,000 156,603,000 53,034,000 30,256,000 70,810,000 27,662,000 46,500,000 71,259,000 66,313,000 33,419,000 88,076,000 56,942,000 49,974,000 76,758,000 58,063,000 73,381,000 91,705,000 62,391,000 70,506,000 73,658,000 
      distribution from equity investment
    		                                                                     
      net cash (used) provided by investing activities
    		                                                                     
      net cash used by financing activities
    		                                                       -22,057,000       -136,379,000 -70,821,000 -34,308,000 -90,372,000 -44,290,000 -69,475,000 -50,602,000 
      gain on disposal of assets
    		                                       1,217,000 1,436,000 209,000 551,000                 -40,000 -35,000 456,000  44,000 -216,000 4,797,000 -99,000 -21,000  
      benefit from deferred income taxes
    		                            2,203,000 1,292,000 4,318,000  1,105,000 1,341,000 5,780,000 3,810,000 1,775,000 2,641,000 9,270,000 6,228,000 1,459,000 3,161,000 8,415,000 6,764,000 3,330,000 3,865,000 7,655,000 2,573,000 3,180,000 10,132,000 8,310,000 3,082,000 10,716,000 3,724,000 5,675,000 4,071,000         808,000    -634,000 
      fair-value adjustments for contingent liabilities
    		                            -27,000       320,000    38,000       0       0 0 900,000              
      decrease in accounts payable and accrued expenses
    		                                                     9,949,000 -7,396,000 -19,515,000 11,668,000 17,256,000 -46,127,000 6,961,000 8,699,000 -31,597,000  14,774,000 -35,518,000  14,445,000 -20,779,000  
      cash paid for amended and restated credit agreement
    		                            0                                         
      decrease in receivables
    		                             5,347,000 3,424,000                             3,839,000 4,453,000 554,000        
      decrease in prepaid expenses and other assets
    		                              861,000          4,970,000 -424,000 1,574,000    2,801,000   7,017,000   4,501,000   6,619,000   20,333,000   3,523,000   8,911,000     
      impairment of assets
    		                               0 0   0 0   0    0          0   0 6,956,000 0 1,000,000 0 20,163,000        
      net sales (purchases) of trading securities
    		                               2,322,000 1,123,000 11,063,000 2,516,000            130,000                       
      purchases of securities available for sale
    		                                                     -60,712,000 -699,000 -10,697,000 -7,439,000 -50,341,000 -422,000 -6,000 -5,000 -1,272,000 -4,000 -3,000 -4,000 -104,000 -1,005,000 -1,003,000 -106,000 
      proceeds from redemptions of securities available for sale
    		                               113,867,000 9,033,000 4,899,000 12,450,000 10,000 7,829,000 101,000 50,000 5,755,000 1,000 0 0 0 45,424,000 32,322,000 9,371,000 32,559,000 44,052,000 11,758,000 6,405,000 51,594,000 17,949,000 15,884,000 -1,000 10,912,000 45,065,000 232,000 105,000 1,000 -1,000 1,000 0 1,000 11,034,000 0 1,000 996,000 5,818,000 
      excess tax benefits from share-based compensation
    		                                   0 0 -596,000 596,000 1,103,000 343,000 542,000 1,656,000 954,000 344,000 361,000 1,007,000 331,000 317,000 463,000 283,000 299,000 463,000 -241,000 -286,000 -920,000 -259,000 -288,000 -2,155,000 -272,000 -477,000 -205,000 -5,485,000 -443,000 -706,000 -1,782,000 -1,745,000 -1,494,000  
      net increase in cash and cash equivalents
    		                               154,854,000 46,242,000       31,471,000        -9,132,000   98,237,000 33,722,000 2,252,000 -22,452,000   16,742,000 164,369,000 -48,879,000 17,877,000 -8,497,000 6,183,000  -29,426,000 50,103,000   -7,330,000  
      cash and cash equivalents, beginning of year
    		                                                                     
      cash and cash equivalents, end of year
    		                                                                     
      decrease (increase) in prepaid expenses and other assets
    		                                                                     
      cash and cash equivalents, beginning of period
    		                                0 0 104,839,000  0 0 172,628,000  0 0 115,267,000  0 0 104,443,000 0 0 67,585,000 0 0 49,273,000 0 0 198,756,000 0 0 90,452,000 0 0 45,438,000 0 0 120,350,000 0 0 118,721,000 0 
      cash and cash equivalents, end of period
    		                                46,242,000 20,539,000 94,629,000  31,244,000 6,098,000 147,762,000  32,070,000 17,254,000 91,833,000  29,384,000 -10,494,000 71,575,000 -9,132,000 30,967,000 56,427,000 98,237,000 33,722,000 51,525,000 -22,452,000 -21,577,000 176,825,000 16,742,000 164,369,000 41,573,000 17,877,000 -8,497,000 51,621,000 -96,146,000 -29,426,000 170,453,000 -48,404,000 -5,924,000 111,391,000 -73,286,000 
      decrease (increase) in receivables
    		                                 1,128,000 98,000         669,000 -195,000 681,000 666,000         916,000       1,166,000 1,755,000 360,000    -1,175,000 
      net decrease in cash and cash equivalents
    		                                                       -21,931,000          -48,404,000    
      net purchases of trading securities
    		                                                     -109,000 -1,227,000 -6,487,000 -639,000 -35,000 -2,774,000 -3,465,000 -439,000 -4,889,000 -2,230,000 -1,506,000 -651,000 -823,000   -68,000 
      net cash used by investing activities
    		                                                     -48,961,000 -4,773,000 -46,374,000 -13,558,000      -38,687,000   -51,094,000 -24,841,000 -9,711,000 -97,249,000 
      loss on disposal of assets
    		                                    23,000 220,000 1,174,000                   -193,000 492,000           
      net (purchases) sales of trading securities
    		                                                                   -6,257,000  
      cash paid for contingent liabilities
    		                                                                     
      tax benefit from share-based compensation
    		                                              983,000       56,000 -145,000 217,000       7,284,000 447,000 746,000 1,758,000 2,092,000 2,146,000  
      net income including noncontrolling interests in subsidiaries
    		                                               37,630,000 41,861,000 44,688,000       48,063,000 48,275,000 44,195,000 60,286,000          
      tax benefit (detriment) from share-based compensation
    		                                                 173,000       143,000 -211,000 1,604,000           
      net cash from investing activities
    		                                                20,252,000 4,451,000         -3,305,000 -5,453,000 -22,099,000 -7,773,000        
      net income including noncontrolling interest in subsidiaries
    		                                                  58,193,000 43,073,000 44,407,000 38,521,000 42,884,000 35,054,000              
      tax (detriment) benefit from share-based compensation
    		                                                           133,000 560,000 -1,037,000        
      payments on debt—recourse
    		                                                                     
      payments on debt—nonrecourse
    		                                                                     
      proceeds from sale of certain b-share-related future revenue
    		                                                     0 0 0 2,000 31,000 1,190,000 1,363,000 1,452,000 1,107,000 1,278,000 1,849,000 1,810,000     
      increase in income taxes payable
    		                                                     -96,000 -6,270,000 7,935,000 533,000 -5,804,000 6,350,000 598,000 -22,795,000 23,676,000 -322,000 -21,235,000 22,398,000 796,000 -21,830,000 22,670,000 -23,000 
      cash paid for purchased loans
    		                                                     0   -41,429,000             
      proceeds from disposal of property and equipment
    		                                                     0 0 0 0 0 3,298,000           
      proceeds from new borrowings – recourse
    		                                                     0 0 0 0 309,500,000 97,500,000 0 26,500,000 28,300,000        
      proceeds from new borrowings – nonrecourse
    		                                                     0 0 0 0 10,000 261,000 299,000 319,000 243,000 281,000 406,000 397,000 379,000 220,000 3,206,000 3,969,000 
      payments on debt – recourse
    		                                                     -10,625,000 -10,625,000 -10,625,000 -10,625,000 -85,250,000 -22,750,000 -25,524,000 -36,324,000 -40,523,000        
      payments on debt – nonrecourse
    		                                                     -152,000 -1,568,000 -2,055,000 -2,249,000 -2,585,000 -2,549,000 -5,015,000 -5,025,000 -5,560,000 -8,991,000 -9,911,000 -11,033,000 -13,627,000 -13,672,000 -14,010,000 -14,974,000 
      net cash (used) provided by financing activities
    		                                                     -44,301,000                
      other
    		                                                        0             
      decrease in other liabilities
    		                                                          -434,000           
      net cash from financing activities
    		                                                          -78,993,000 -64,746,000 -43,340,000 -41,758,000        
      adjustments to reconcile net income including noncontrolling interests in subsidiaries to net cash from operating activities
    		                                                                     
      proceeds from disposal of business
    		                                                                     
      net income
    		                                                             37,469,000 56,212,000 58,024,000 55,819,000 57,728,000 55,277,000 51,763,000 45,609,000 
      adjustments to reconcile net income attributable to federated investors, inc. to net cash from operating activities
    		                                                                     
      additions to property and equipment
    		                                                             -5,740,000 -2,162,000 -2,104,000 -2,230,000 -1,357,000 -816,000 -1,350,000 -907,000 
      minority interest
    		                                                              2,455,000 2,020,000 1,386,000 1,469,000 1,400,000 1,376,000 1,359,000 
      (gain) loss on disposal of business and assets
    		                                                                     
      cash paid for business acquisitions and minority interest investments
    		                                                              -41,321,000   -49,633,000    
      decrease in restricted cash equivalents
    		                                                              0 0 0 0 0 29,000  
      distributions to minority interest
    		                                                              -3,391,000 -1,171,000 -1,342,000 -1,342,000 -2,042,000 -869,000 -1,298,000 
      contributions from minority interest
    		                                                              105,000 73,000 60,000 906,000 587,000 1,722,000 0 
      proceeds from shareholders for share-based compensation and other
    		                                                                339,000 4,187,000 1,009,000 734,000  
      increase in other assets
    		                                                                 -8,815,000   -9,069,000 
      net proceeds from disposal of business, equipment and other assets
    		                                                                    273,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                                                                     
      net proceeds from disposal of business
    		                                                                  0 0  
      decrease (increase) in other assets
    		                                                                   403,000  
      stock-based compensation expense
    		                                                                    2,759,000 
      tax benefit from stock-based compensation
    		                                                                    9,425,000 
      excess tax benefits from stock-based compensation
    		                                                                    -9,051,000 
      increase in other current liabilities
    		                                                                    3,872,000 
      increase in other long-term liabilities
    		                                                                    240,000 
      decrease (increase) in restricted cash equivalents
    		                                                                     
      proceeds from shareholders for stock-based compensation and other
    		                                                                     
      proceeds from shareholders for stock-based compensation
    		                                                                     
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.